• 840

Research Offers Hope for Spinal Cord Injuries: How a Clinical Trial in Dogs May Help Human Patients

How a Clinical Trial in Dogs May Help Human Patients

Dr. Johnathan Levine
Dr. Jonathan Levine

Dr. Jonathan Levine’s research on spinal cord injuries in dogs may one day help humans with similar injuries. The United States Department of Defense seems to think so, as they have funded a large-scale, three-year clinical trial of dogs with injuries resulting from intervertebral disc herniation. While humans with spinal cord injuries (SCIs) usually sustain these due to trauma, canine disc herniation does mimic certain facets of human injury.

Tracking limb movement
Using infrared cameras that track limb movements, the team measure how normal versus injured dogs walk.

Importantly, canine disc herniation results in spinal cord bruising and compression, as is the case with trauma in humans. Additionally, the treatment for canine disc herniation is amazingly similar to that which is administered to humans with spinal cord trauma.

“The animals get an MRI, they get surgery, and they get rehabilitation,” said Levine, who is an associate professor in the Department of Small Animal Clinical Sciences at the Texas A&M College of Veterinary Medicine & Biomedical Sciences.

Using dogs with naturally occurring neurological conditions, as opposed to rodents with induced injuries, gives a much more realistic view of how a drug might perform in humans. However, the study is also much more complicated because the researchers don’t have control over a number of factors. Unlike rodents, dogs vary widely in their genetics, the location and severity of the injury, and time before treatment begins. Human SCIs, of course, have similar variability.

“If a drug doesn’t work on dogs, that is a good indication that it might not work in humans either,” Levine said. On the other hand, of course, something that does work well in dogs is very promising for human injuries.

One of the ways to determine if a treatment works is to measure recovery of various functions, especially movement. Using infrared cameras that can track limb movements, Levine and his team measure how normal versus injured dogs walk. Then, in separate collaborative projects with bioengineers at the University of Louisville, the team can determine which muscles are activated.

“It is a very collaborative process,” Levine said. “There are about 20 people, at a number of different institutions, who are vital to our entire program.”  The study with the U.S. Department of Defense is a joint effort with investigators at UC San Francisco Medical School. Scientists at University of Louisville, Methodist Hospital, and UT Houston Medical School are participating in an array of other projects.

“Dr. Levine’s approach is a perfect example of One Health research,” said Dr. Eleanor M. Green, the Carl B. King Dean of Veterinary Medicine. “The goal of his trial is to determine how best to treat dogs with this common injury, but in so doing he is gathering valuable data that can be used to benefit future human clinical trials.”

Technicians fit sensors that will measure the dog’s limb movement.
Technicians fit sensors that will measure the dog’s limb movement.

The drug Levine and his colleagues are evaluating in the U.S. Department of Defense canine clinical trial is a type of neuro-protective therapy, meaning it is thought to protect the cord by stopping events that happen soon after injury that actually make injury worse. Specifically, the drug blocks enzymes called metalloproteinases that are released after injury. These enzymes break down the extracellular matrix and allow white blood cells into the spinal cord, which only does more damage. However, these same enzymes can be useful at later stages of injury, after the body has started the healing process and has begun to form scar tissue. When the enzymes are inhibited at later stages, the patients tend to do poorly, which is why the drug therapy has to be timed perfectly.

“If we can get to these dogs in the first 48 hours after their injury,” Levine said, “we can give this drug—and the dogs—their optimal chance.”

If you have a dog or a patient you think might be a candidate for Levine’s clinical trial, please contact Alisha Selix (aselix@cvm.tamu.edu) or Elizabeth Scanlin (escanlin@cvm.tamu.edu) at 979-845-2351.

###

 

 

For more information about the Texas A&M College of Veterinary Medicine & Biomedical Sciences, visit our website atvetmed.tamu.edu or join us on Facebook.

Contact Information

Megan Palsa
mpalsa@cvm.tamu.edu
979-862-4216
979-421-3121

 ·   · 24 posts
  •  · 938 friends
Comments (0)
Info
Category:
Created:
Updated:
Featured Posts

San Antonio Vicious Dog Ordinance Bites

  •  · 
  •  · gsicard
This article was written by Zandra Anderson, a lawyer in San Antonio, TX who specializes in pet law. The entire article is quoted below "It appears that a proposed vicious dog law in San Antonio could put nearly every dog that breathes in danger of being labeled vicious. San Antonio is considering one of the worst dog ordinances I have ever seen. Below is the proposed language–read it very carefully and keep in mind that the definition of enclosure includes your house and fenced yard. PLEASE–fax, call & email (addresses & numbers below)! Talking points are provided below. This is a bad law and can set precedent for other cities. The vote is this Thursday, 12/13/07, so you have t

The Calgary Model

  •  · 
  •  · admin
The Calgary Model   The animal control bylaw in Calgary, Alberta, Canada has been hailed by many as a HUGE success.  While other cities and provinces in Canada are banning breeds, Calgary is choosing education program and stronger enforcement.  What's the end result?  By all accounts, reports and statistics, the bylaw is working!   Not only that, the bylaw works so well and the results are so highly praised, Calgary is inspiring animal control officials outside of Canada to use the bylaw as a model for their own animal control ordinances.     The following is written by Dana Grove:   The bylaw officers in Calgary have taken a stand against breed banning, and responded to dog bite con

Molosserdogs Future

  •  · 
  •  · gsicard
I have seen the popularity and visits to many websites drop significantly. Theree was a belief that over time we would see static webcontent give way to smaller communities centered around particular interests where smaller groups of individual have commom interests. Sites like Facebook, pInterest, twitter, and new offerings from the big 3 (google, microsoft, Yahoo) mak it very difficult for smaller sites to popular again. It was partly that reason why i changed the format of MD to a community site to give members a site with features similar to fb but more community centric. Only the future will tell how we progress but i will keep molosserdogs.com running as long as i am able.